Neuropsychiatric disorders related to interferon and interleukins treatment

Author： Myint Aye Schwarz Markus Steinbusch Harry Leonard Brian

ISSN： 0885-7490

Source： Metabolic Brain Disease, Vol.24, Iss.1, 2009-03, pp. : 55-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Halogenated Derivatives of Aromatic Amino Acids Exhibit Balanced Antiglutamatergic Actions: Potential Applications for the Treatment of Neurological and Neuropsychiatric Disorders

Recent Patents on CNS Drug Discovery, Vol. 1, Iss. 3, 2006-11 ,pp. : 261-270

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives

Recent Patents on CNS Drug Discovery, Vol. 7, Iss. 1, 2012-04 ,pp. : 25-40

Bentham Science Publishers

Access to resources Recommend Favorite

Intralesional Human Leukocyte Interferon Treatment Alone or Associated with IL‐2 in Non‐AIDS Related Kaposi's Sarcoma

THE JOURNAL OF DERMATOLOGY, Vol. 19, Iss. 1, 1992-01 ,pp. : 35-39

John Wiley & Sons Inc

Access to resources Recommend Favorite

Psychiatric Side Effects of Interferon Treatment

Current Drug Safety, Vol. 1, Iss. 2, 2006-05 ,pp. : 143-150

Bentham Science Publishers

Access to resources Recommend Favorite

Investigations of Interferon-Lambda for the Treatment of Cancer

Journal of Innate Immunity, Vol. 7, Iss. 3, 2015-02 ,pp. : 243-250

Karger

Access to resources Recommend Favorite